Form 4: Vertex Pharmaceuticals Executive Amit Sachdev Reports Stock Disposal
SEC Form 4 Filing
Amit Sachdev, EVP Chief Patient & External Affairs Officer at Vertex Pharmaceuticals, reported the disposal of 3,703 shares of common stock to cover tax obligations.
Summary
- On February 26, 2025, Amit Sachdev, an executive at Vertex Pharmaceuticals, disposed of 3,703 shares of common stock.
- The transaction was executed at a price of $479.61 per share.
- Following the transaction, Sachdev directly owns 68,490 shares of Vertex Pharmaceuticals common stock.
- Sachdev also indirectly owns 882 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small percentage of the company's outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of stock disposal transaction |
| 02/28/2025 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.